These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5155959)

  • 21. Determinants of the response to oral anticoagulant drugs in man.
    O'Reilly RA; Aggeler PM
    Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
    [No Abstract]   [Full Text] [Related]  

  • 22. Factor XI as a target for antithrombotic therapy.
    Bane CE; Gailani D
    Drug Discov Today; 2014 Sep; 19(9):1454-8. PubMed ID: 24886766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the clot-promoting effect of skin.
    Ogston D; Ogston CM; Ratnoff OD
    J Lab Clin Med; 1969 Jan; 73(1):70-7. PubMed ID: 5762166
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug interactions with anticoagulants.
    Sigell LT; Flessa HC
    JAMA; 1970 Dec; 214(11):2035-8. PubMed ID: 5536475
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of ACTH, heparin & salicylate on blood coagulation.
    Belsare SD
    Indian J Exp Biol; 1981 May; 19(5):506-7. PubMed ID: 6268534
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of the in vitro anti-aggregating action of various salicylic derivatives].
    Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):89-92. PubMed ID: 7325722
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mechanism of an increase in the hemostatic properties of the blood under the influence of adrenaline (experimental in vitro studies)].
    Popova LG; Nikiforova LM
    Probl Gematol Pereliv Krovi; 1974; 19(5):46-8. PubMed ID: 4830589
    [No Abstract]   [Full Text] [Related]  

  • 29. Method of purification and properties of anti-XIa (inhibitor of the contact product).
    Niemetz J; Nossel HL
    Thromb Diath Haemorrh; 1967 May; 17(3-4):335-48. PubMed ID: 5589293
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of IgM antibodies which inhibit the contact activation of blood coagulation.
    Criel A; Collen D; Masson PL
    Thromb Res; 1978 May; 12(5):883-92. PubMed ID: 566967
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of Clofibrate on blood coagulation].
    Barth P; Kommerell B
    Med Klin; 1966 Sep; 61(37):1466-8. PubMed ID: 4867653
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the anticoagulant action of aprotinin ("trasylol").
    Prentice CR; Mcnicol GP; Macnicol GP; Douglas AS
    Thromb Diath Haemorrh; 1970 Oct; 24(1):265-72. PubMed ID: 5312434
    [No Abstract]   [Full Text] [Related]  

  • 33. [Examination of the plasma clotting activities--determination of contact factors XII, XI].
    Murakami M; Umeda T
    Rinsho Byori; 1969; 16():Suppl 16:66-74. PubMed ID: 5391587
    [No Abstract]   [Full Text] [Related]  

  • 34. [Estimation of blood coagulation time by the coagulometer and quality control and evaluation of the test during anticoagulant administration].
    Matsuno M; Hashimoto T; Sakamoto M
    Rinsho Byori; 1971 Aug; 19():Suppl:62-3. PubMed ID: 5168180
    [No Abstract]   [Full Text] [Related]  

  • 35. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methods and results of hematologic studies in the field of dental surgery].
    Schulte W
    Dtsch Zahnarztl Z; 1966 Apr; 21(4):560-77 contd. PubMed ID: 5218359
    [No Abstract]   [Full Text] [Related]  

  • 37. The enigma of severe factor XI deficiency without hemmorrhagic symptoms. Distinction from Hageman factor and "Fletcher factor" deficiency; family study; and problems of diagnosis.
    Edson JR; White JG; Krivit W
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):342-8. PubMed ID: 5590232
    [No Abstract]   [Full Text] [Related]  

  • 38. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

  • 40. [Activity of eterilate, benorylate and acetylsalicylic acid on blood glucose in normal and experimentally diabetic rats].
    Alonso S; Ortega MP; Armijo M
    Arch Farmacol Toxicol; 1983 Aug; 9(2):183-90. PubMed ID: 6140900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.